Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma

1. Martinez-Lopez, J.
2. Alonso, R.
3. Wong, S.W.
4. Rios, R.
5. Shah, N.
6. Ruiz-Heredia, Y.
7. Sanchez-Pina, J.M.
8. Sanchez, R.
9. Bahri, N.
10. Zamanillo, I.
11. Poza, M.
12. Buenache, N.
13. Encinas, C.
14. Juarez, L.
15. Miras, F.
16. Collado, L.
17. Barrio, S.
18. Martin, T.
19. Cedena, M.T.
20. Wolf, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1186/S13045-021-01135-W GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus